Clinical Trial

Effects of Unilateral, Bilateral and Combined Resistance Training on the Speed and Accuracy of the Serve in Youth Tennis Players

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study is to explore the effects of unilateral, bilateral and combined resistance training on the serve speed and accuracy of amateur youth tennis players in China. The subjects were young male tennis players aged 16-20 years from four universities in Gansu Province. The experiment was divided into control group (CG), experiment group 1 (EG1-unilateral group), experiment group 2 (EG2-bilateral group) and experiment group 3 (EG3-combined group). Used to compare the effects of different forms of resistance training on serve speed and accuracy. Previous studies have shown that unilateral and bilateral resistance training can effectively improve strength, power, and speed in athletes (Speirs, et al., 2016; Davo, Jimenez, \& Solana,. , 2018), there is still controversy when comparing the advantages and disadvantages of two forms of resistance training (Ramirez-Campillo et al., 2015; Donab and Wall. The results of this study will be expected to be updated in 2022. Unilateral resistance training, bilateral resistance training, and combined unilateral and bilateral resistance training were used as intervention models in this study. Based on the literature review, the training frequency of this experiment was arranged as 2 times/week, and the total training time was 6 weeks, with a fixed duration of each training session. Each training session lasted a maximum of 60 minutes. In this experiment, the interval between the two weekly training sessions was at least 24 h to prevent subjects from being in a fatigued state in the relevant muscle groups of the body and affecting the experimental level.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-15.
Trial Details
NCT Number NCT06419452
Lead Sponsor Universiti Putra Malaysia
Conditions Exercise Training
Enrollment 56 participants
Start Date 2024-05-10
Primary Completion 2024-06-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-04